Lantheus Holdings (LNTH) Current Deferred Revenue (2023 - 2026)
Lantheus Holdings (LNTH) posted quarterly Current Deferred Revenue of $6.6 million for Q1 2026, down 5.56% quarter-over-quarter from $7.0 million in Q4 2025.
Lantheus Holdings (LNTH) Current Deferred Revenue (2023 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Current Deferred Revenue for 4 consecutive years, with $6.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Deferred Revenue changed N/A year-over-year to $6.6 million; the TTM figure through Mar 2026 stood at $6.6 million (changed N/A YoY), while the FY2025 annual figure was $7.0 million, up 382.65% from the prior year.
- Current Deferred Revenue slipped to $6.6 million in Q1 2026 per LNTH's latest filing, from $7.0 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $7.0 million in Q4 2025 and bottomed at $1.4 million in Q4 2024.
- Historically, Current Deferred Revenue has averaged $4.1 million across 4 years, with a median of $4.0 million in 2023.
- Annual changes were most pronounced in 2024 — Current Deferred Revenue decreased 2.82% — and 2025, when it surged 382.65%.
- Lantheus Holdings' Current Deferred Revenue stood at $1.5 million in 2023, then slipped by 2.82% to $1.4 million in 2024, then soared by 382.65% to $7.0 million in 2025, then dropped by 5.56% to $6.6 million in 2026.
- Business Quant data shows LNTH's Current Deferred Revenue at $6.6 million in Q1 2026, $7.0 million in Q4 2025, and $1.4 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.40 Bn | 43.44 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.90 Bn | 40.24 Bn | 2.15 Bn |
| 3 | Zoetis | 32.45 Bn | 30.78 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.97 Bn | 18.08 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.52 Bn | 15.13 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - |
| 10 | Lantheus Holdings | 6.53 Bn | 5.94 Bn | 241.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.45 Mn |
| Mar 31, 2026 | 6.60 Mn |
| Dec 31, 2025 | 6.98 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Dec 31, 2023 | 1.49 Mn |